Astellas Pharma Inc. Chases CV Therapeutics, Inc. (JOBS) After Snubbed Bid

February 23, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

TOKYO, Feb 23 (Reuters) - Astellas Pharma Inc, Japan's second-largest drugmaker, said on Monday it would continue to pursue U.S. biotech firm CV Therapeutics, which has rejected its $1 billion buyout offer.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions Asia

Astellas Pharma US, Inc.